• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
ProPhase Labs’ Resolution for 2025: Nail Down a ‘Liquidity Event’

ProPhase Labs’ Resolution for 2025: Nail Down a ‘Liquidity Event’

by Ron Shinkman | Jan 9, 2025 | Deals-lir, Essential, Lab Industry Advisor

The company has lost nearly $36 million since 2023, but its CEO is aggressively pursuing new revenue options

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Dx Deals: New Premerger Regulations Could Slow Down Pace of Transactions

Dx Deals: New Premerger Regulations Could Slow Down Pace of Transactions

by Ron Shinkman | Nov 27, 2024 | Deals-lir, Essential, Lab Industry Advisor

The new rules, which were approved by the FTC in October and will go into effect in mid-January, aim to put a damper on consolidation

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Dx Deals: More than $62 Million Invested in Startup Labs in Recent Weeks

Dx Deals: More than $62 Million Invested in Startup Labs in Recent Weeks

by Ron Shinkman | Oct 1, 2024 | Deals-lir, Essential, Lab Industry Advisor

The rounds of funding to Clarapath, PreciseDx, and Precision Epigenomics come at a time when other M&A activity is seasonally slow

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Labcorp Goes on Spring Spending Spree

Labcorp Goes on Spring Spending Spree

by Ron Shinkman | Jun 4, 2024 | Deals-lir, Essential, Lab Industry Advisor

Most of Invitae's employees will be hired by Labcorp, which expects the deal to add about $275 million in annual revenue

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Dx Deals: New Deal Expands Reach of Oral Cancer Test to Dental Practices

Dx Deals: New Deal Expands Reach of Oral Cancer Test to Dental Practices

by Ron Shinkman | May 1, 2024 | Deals-lir, Essential, Lab Industry Advisor

Recently announced collaboration between Viome and Henry Schein allows dentists to offer sample collection for Viome’s assay to patients

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
« Older Entries

Sign up for our free weekly Lab & Pathology Insider email newsletter

Log In

Join Now | Lost Password?
  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
Copyright © 2025 G2Intelligence.com